๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

โœ Scribed by Susanna Esposito; Lorenza Pugni; Samantha Bosis; Alice Proto; Laura Cesati; Ciro Bianchi; Carolyn Cimino; Fabio Mosca; Nicola Principi

Book ID
116957645
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
76 KB
Volume
23
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunogenicity and safety of fully liqui
Immunogenicity and safety of fully liquid DTaP5-IPV-Hib compared with DTaP3-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: A phase III, single-blind, randomised, controlled, multicentre study
โœ Emmanuel Grimprel; Jacek Wysocki; Florence Boisnard; Stรฉphane Thomas; Grace Mwaw ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 338 KB
Safety and immunogenicity of fully liqui
Safety and immunogenicity of fully liquid DTaP5-IPV-Hib pediatric combination vaccine (Pediacelยฎ) compared to DTaP3-HBV-IPV/Hib (Infanrixยฎ Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11โ€“18 months of age: A phase III, modified double-blind, randomized, controlled, multicenter study
โœ Reinhard Berner; Florence Boisnard; Stรฉphane Thomas; Grace Mwawasi; Donna Reynol ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 303 KB
Immunogenicity and safety study of a new
Immunogenicity and safety study of a new DTaPโ€“IPVโ€“Hep Bโ€“PRP-T combined vaccine compared to a licensed DTaPโ€“IPVโ€“Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants
โœ Pope Kosalaraksa; Usa Thisyakorn; Suwat Benjaponpitak; Kulkanya Chokephaibulkit; ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 290 KB